Clinical Trials Browser

Phase 2 × Completed × FED × Clear all

NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

Phase 2 Completed

28 enrolled 10 charts

Newly Diagnosed Oligometastatic Prostate Cancer

NCT04390880 2025-05-16

PROSPYL

Phase 2 Completed

239 enrolled 5 charts

Prostatic Neoplasms

NCT01759771 2024-03-18

VD3PCa

Phase 2 Completed

130 enrolled 13 charts

Prostatic Neoplasms

NCT00524277 2020-03-30

Vaccine Therapy in Treating Patients With Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT01754909 2019-10-08

Mitigation of Radiation Pneumonitis and Fibrosis

Phase 2 Completed

50 enrolled 10 charts

Lung Neoplasms, Radiation Pneumonitis

NCT00780234 2019-04-11

Pioglitazone for Lung Cancer Chemoprevention

Phase 2 Completed

92 enrolled 9 charts

Lung Neoplasms

NCT00953225 2017-10-09

vit D & PCa

Phase 2 Completed

83 enrolled 8 charts

Prostatic Neoplasms

NCT00105599 2015-04-07

Effectiveness of the FairCare System for Patients With Advanced Illness

Phase 2 Completed

Neoplasms

NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

Phase 2 Completed

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

NCT00004688 2015-03-25

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Genetic Diseases, Inborn, Rare Diseases

NCT00056992 2015-03-25

Testing of ADI-PEG in Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00086203 2015-03-25

Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00098033 2015-03-25

Investigation of Clofarabine in Acute Leukemias

Phase 2 Completed

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00099593 2015-03-25

Immunization Against Tumor Cells in Sezary Syndrome

Phase 2 Completed

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT01032928 2015-01-01

RSPT

Phase 2 Completed

30 enrolled 9 charts

Deglutition Disorders, Oropharyngeal Neoplasms, Respiratory Aspiration

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00018538 2009-01-21

Calcifidol Therapy in Men With Cancer

Phase 2 Completed

Prostatic Neoplasms, Recurrence

NCT00018551 2009-01-21

Chemoprevention With Folic Acid

Phase 2 Completed

Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps

NCT00108290 2008-04-04

Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms